Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Prothionamide

Prothionamide

pharmaceutical raw materials
Prothionamide structure

Prothionamide 

structure
  • CAS No:

    14222-60-7

  • Formula:

    C9H12N2S

  • Chemical Name:

    Prothionamide

  • Synonyms:

    4-Pyridinecarbothioamide,2-propyl-;Isonicotinamide,2-propylthio-;2-Propyl-4-pyridinecarbothioamide;2-Propylthioisonicotinamide;Prothionamide;Trevintix;Ektebin;Protionamid;2-Propylisonicotinylthioamide;9778 R. P.;Tebeform;1321TH;Tuberex;Protion;Protionamide;Protionizina;TH 1321;RP 9778;2-Propylpyridine-4-thiocarboxamide;Peteha;Tuberamin;2-Propylpyridine-4-carboimidothioic acid

  • Categories:

    Active Pharmaceutical Ingredients  >  Synthetic Anti-infective Drugs

Description

Protionamide is Yellow Solid


Prothionamide is a member of pyridines.|Prothionamide has been used in trials studying the treatment of MDR-TB and HIV Infections.|Protionamide is a thioamide derivative with antitubercular activity. Protionamide forms a covalent adduct with bacterial nicotinamide adenine dinucleotide (NAD), PTH-NAD, which competitively inhibits 2-trans-enoyl-ACP reductase (inhA), an enzyme essential for mycolic acid synthesis. This results in increased cell wall permeability and decreased resistance against cell injury eventually leading to cell lysis. Mycolic acids, long-chain fatty acids, are essential mycobacterial cell wall components and play a key role in resistance to cell injury and mycobacterial virulence.|Antitubercular agent similar in action and side effects to ETHIONAMIDE. It is used mostly in combination with other agents.

Prothionamide Basic Attributes

180.27

180.27

238-093-7

76YOO33643

758962

DTXSID7045940

C72605

J - Antiinfectives for systemic use

2933399090

Characteristics

71

1.5

1.1015 (rough estimate)

136.7 °C

310.4±44.0 °C(Predicted)

141.5±28.4 °C

1.5300 (estimate)

Refrigerator

LD50 in mice, rats (g/kg): 1.0, 1.32 orally (Il'in)

141.3 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]

Safety Information

IRRITANT

NONH for all modes of transport

NS0650000

P264, P270, P301+P312, P330, P501

H302

|Warning|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P264, P270, P301+P312, P330, and P501|Aggregated GHS information provided by 129 companies from 2 notifications to the ECHA C&L Inventory.

Drug Information

Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. (See all compounds classified as Antitubercular Agents.)

ektebin

Prothionamide Use and Manufacturing

Methods of Manufacturing

General procedure: THF (5ml/mmol) was added to a flask containing pyridine-4-carboxamide derivative (1 eq) at room temperature under inert atmosphere (argon) and stirring. Lawesson's reagent (1.5 eq) was added to the flask and the solution was stirred at room temperature for 48h-72h. The THF was evaporated under reduce pressure and the residue was partitioned between saturated aqueous NaHCO

Uses

An anti-tuberculosis agent. It has also been used to treat Leprosy. Antibacterial (tuberculostatic).

Computed Properties

Molecular Weight:180.27
XLogP3:1.5
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:2
Rotatable Bond Count:3
Exact Mass:180.07211956
Monoisotopic Mass:180.07211956
Topological Polar Surface Area:71
Heavy Atom Count:12
Complexity:159
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Drug Function and Efficacy

This product is a derivative of isonicotinic acid. Its mechanism of action is unknown. It may have an inhibitory effect on peptide synthesis. The effect of this product on Mycobacterium tuberculosis depends on the drug concentration at the infected site. It only has an antibacterial effect at low concentrations and a bactericidal effect at high concentrations. It inhibits the synthesis of mycolic acid in Mycobacterium tuberculosis. This product has partial cross-resistance with ethionamide.

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • Jiangxi Tianxu Pharmaceutical Co., Ltd.

    China China
    Active
  • Jiangsu Cixing Pharmaceutical Co., Ltd.

    China China
    Active
  • Liaoning PHARMA-UNION Pharmaceutical Co., Ltd.

    China China
    Active

Recommended Suppliers of Prothionamide

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.